Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers
Authors
- Liangjia Bi (ORCID: https://orcid.org/0000-0001-8635-427X)
- Wanjun Bai (ORCID: https://orcid.org/0009-0008-3266-8765)
- Yufang F. Xu (ORCID: https://orcid.org/0000-0003-4946-4722)
- Caiyun Jia (ORCID: https://orcid.org/0000-0001-6436-9075)
- Jian Zhang (ORCID: https://orcid.org/0000-0002-7240-3541)
- Na Zhao (ORCID: https://orcid.org/0000-0003-3655-7145)
- Bo Qiu (ORCID: https://orcid.org/0000-0002-7741-7969)
- Haojing Song
- Yiting Hu (ORCID: https://orcid.org/0000-0001-8538-0337)
Institutions
- Hebei General Hospital (CN)
- Shijiazhuang Yiling Pharmaceutical (China) (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/dddt.s518617
- Citations
- 1
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.52